Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 9, 2019 | Grant | $719.70K | 1 | National Science Foundation | — | Detail |
Aug 1, 2018 | Grant | $225K | 2 | National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
National Institutes of Health | Yes | Grant |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Yes | Grant |